Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project
出版年份 2022 全文链接
标题
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project
作者
关键词
-
出版物
Biomedicines
Volume 10, Issue 12, Pages 3280
出版商
MDPI AG
发表日期
2022-12-19
DOI
10.3390/biomedicines10123280
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Risk of infections with ustekinumab and tofacitinib compared to tumor necrosis factor α antagonists in inflammatory bowel diseases
- (2022) David Cheng et al. Clinical Gastroenterology and Hepatology
- Clinical Manifestations of Leukocytoclastic Vasculitis, Treatment, and Outcome in Patients with Ulcerative Colitis: A Systematic Review of the Literature
- (2022) Ivana Pantic et al. Journal of Clinical Medicine
- Incident Colorectal Cancer in Inflammatory Bowel Disease
- (2022) Benedetto Neri et al. Cancers
- Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland
- (2022) Kathrin Perrig et al. Therapeutic Advances in Gastroenterology
- Treatment persistence and maintenance dose titration among ulcerative colitis patients on biologics: a pooled study of three United States claim databases
- (2022) Janvi Sah et al. CURRENT MEDICAL RESEARCH AND OPINION
- Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database
- (2022) Maria Antonietta Barbieri et al. Frontiers in Pharmacology
- Model-Based Meta-Analysis on the Efficacy of Biologics and Small Targeted Molecules for Crohn’s Disease
- (2022) Boran Yu et al. Frontiers in Immunology
- Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis
- (2022) Laurent Peyrin-Biroulet et al. BMC GASTROENTEROLOGY
- Leaky Gut in IBD: Intestinal Barrier–Gut Microbiota Interaction
- (2022) Shunying Yu et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Population-based incidence and prevalence of inflammatory bowel diseases in Milan (Northern Italy), and estimates for Italy
- (2021) Emanuele Crocetti et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- The burden of inflammatory bowel disease in Europe in 2020
- (2021) Mirabella Zhao et al. Journal of Crohns & Colitis
- Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review
- (2021) Jo L. W. Lambert et al. Journal of Clinical Medicine
- An Update for Pharmacologists on New Treatment Options for Inflammatory Bowel Disease: The Clinicians’ Perspective
- (2021) Carsten Schmidt et al. Frontiers in Pharmacology
- Novel and Emerging Therapies for Inflammatory Bowel Disease
- (2021) Badr Al-Bawardy et al. Frontiers in Pharmacology
- Superior treatment persistence with ustekinumab in Crohn’s disease and vedolizumab in ulcerative colitis compared with anti‐TNF biological agents: real‐world registry data from the Persistence Australian National IBD Cohort (PANIC) study
- (2021) Yanna Ko et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Risk of Malignancy with Vedolizumab Versus Tumor Necrosis Factor-α Antagonists in Patients with Inflammatory Bowel Diseases
- (2021) Siddharth Singh et al. DIGESTIVE DISEASES AND SCIENCES
- Swapping Versus Dose Optimization in Patients Losing Response to Adalimumab With Adequate Drug Levels
- (2021) Xavier Roblin et al. INFLAMMATORY BOWEL DISEASES
- Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database
- (2021) Maria Antonietta Barbieri et al. Drugs - Real World Outcomes
- Trends in the use of biologicals and their treatment outcomes among patients with inflammatory bowel diseases – a Danish nationwide cohort study
- (2021) Mirabella Zhao et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
- (2021) Juan S Lasa et al. Lancet Gastroenterology & Hepatology
- Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis
- (2021) Siddharth Singh et al. Lancet Gastroenterology & Hepatology
- Gender Differences in Inflammatory Bowel Disease
- (2020) Thomas Greuter et al. DIGESTION
- Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study
- (2020) Maria Antonietta Barbieri et al. Journal of Clinical Medicine
- Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn’s disease patients: a German retrospective chart review
- (2020) Ulf Helwig et al. BMC GASTROENTEROLOGY
- Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy
- (2020) Roberta Roberti et al. CURRENT MEDICAL RESEARCH AND OPINION
- Vedolizumab or TNF-antagonist use and risk of new or recurrent cancer in patients with inflammatory bowel disease with prior malignancy: A retrospective cohort study
- (2020) Amar Vedamurthy et al. Clinical Gastroenterology and Hepatology
- Treat to target: The role of histologic healing in inflammatory bowel diseases: A systematic review and meta-analysis
- (2020) Akshita Gupta et al. Clinical Gastroenterology and Hepatology
- Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies
- (2020) William J Sandborn et al. INFLAMMATORY BOWEL DISEASES
- Real-life experience with 4 years of golimumab persistence in ulcerative colitis patients
- (2020) Marisa Iborra et al. Scientific Reports
- Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy
- (2019) Chao Chen et al. INFLAMMATORY BOWEL DISEASES
- Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients with Inflammatory Bowel Diseases: a Systematic Review and Meta-analysis
- (2019) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Leaky gut: mechanisms, measurement and clinical implications in humans
- (2019) Michael Camilleri GUT
- Overall and comparative safety of biologic and immunosuppressive therapy in inflammatory bowel diseases
- (2019) Ariela Holmer et al. Expert Review of Clinical Immunology
- Persistence with Biologic Treatment in Patients with Inflammatory Bowel Disease: A German Claims Data Analysis
- (2019) Antje Mevius et al. DIGESTION
- Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study
- (2019) Yoon Suk Jung et al. DIGESTIVE DISEASES AND SCIENCES
- A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease
- (2019) Qingdong Guan Journal of Immunology Research
- Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study
- (2018) Anna Viola et al. DIGESTIVE AND LIVER DISEASE
- A Practical Guide to the Safety and Monitoring of New IBD Therapies
- (2018) Benjamin Click et al. INFLAMMATORY BOWEL DISEASES
- Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis
- (2017) Carlos Taxonera et al. INFLAMMATORY BOWEL DISEASES
- Treatment Persistence for Infliximab Versus Adalimumab in Crohnʼs Disease
- (2017) Pablo Olivera et al. INFLAMMATORY BOWEL DISEASES
- Sex Is Associated with Adalimumab Side Effects and Drug Survival in Patients with Crohnʼs Disease
- (2017) Mitchell R. K. L. Lie et al. INFLAMMATORY BOWEL DISEASES
- Vedolizumab as Induction and Maintenance Therapy for Crohnʼs Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy
- (2017) Bruce E. Sands et al. INFLAMMATORY BOWEL DISEASES
- Factors Predicting the Adherence to the Therapy of Italian IBD Patients
- (2017) Cristina Bucci et al. Gastroenterology Research and Practice
- Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study
- (2017) Cristina Scavone et al. Frontiers in Pharmacology
- A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn’s Disease Treated with Adalimumab or Infliximab
- (2016) Kaoru Yokoyama et al. ADVANCES IN THERAPY
- Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study
- (2016) A. Stallmach et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Biological therapy increases the health-related quality of life in patients with inflammatory bowel disease in a clinical setting
- (2016) Anne Sofie Krogh Holdam et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
- (2015) Vito Annese et al. Journal of Crohns & Colitis
- The global burden of IBD: from 2015 to 2025
- (2015) Gilaad G. Kaplan Nature Reviews Gastroenterology & Hepatology
- Cancers Complicating Inflammatory Bowel Disease
- (2015) Laurent Beaugerie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
- (2014) J.F. Rahier et al. Journal of Crohns & Colitis
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Adherence to Anti-TNF Therapy in Inflammatory Bowel Diseases
- (2013) Anthony Lopez et al. INFLAMMATORY BOWEL DISEASES
- Long-term Clinical Experience with Vedolizumab in Patients with Inflammatory Bowel Disease
- (2013) Asit Parikh et al. INFLAMMATORY BOWEL DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now